Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech News Iraq.
Press releases published on June 9, 2025
TransCon® hGH Boosted Treatment Benefits of TransCon® CNP in Children with Achondroplasia at Week 26 Interim Analysis of the Phase 2 COACH Trial
GlobeNewswire
·
June 9, 2025
- For the TransCon CNP treatment-naïve cohort, combination treatment resulted in mean annualized growth velocity (AGV) of 9.14 cm/year, with an improvement in mean ACH height Z-score of +0.53 over 26 weeks - For the TransCon CNP-treated cohort, combination …
George Medicines announces FDA approval of WIDAPLIK™ (telmisartan, amlodipine and indapamide), a new single pill combination treatment for hypertension in adults, including initial treatment
GlobeNewswire
·
June 9, 2025
Novel, single pill, triple combination with a standard dose and two lower doses that can deliver the efficacy benefits of combination therapy, with an established safety profile and good tolerability First and only triple combination for the initial …
Sagimet Biosciences to Host Virtual KOL Event, “A New Mechanism of Action in Treating Acne: Update on Positive Phase 3 Denifanstat Trial for the Treatment of Moderate to Severe Acne” on June 16, 2025
GlobeNewswire
·
June 9, 2025
SAN MATEO, Calif., June 09, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced it will host a …
IN8bio Recognizes Achievement of 4-Years in Remission for Patient Treated with INB-200 in Glioblastoma Trial
GlobeNewswire
·
June 9, 2025
NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies for cancer and autoimmune diseases, announced that Patient 009 in the Phase 1 trial of …
Jade Biosciences Presents JADE101 Preclinical Data at the 62nd European Renal Association Congress Demonstrating Potential for Best-in-Class Profile in IgA Nephropathy
GlobeNewswire
·
June 9, 2025
Preclinical data highlighted JADE101’s femtomolar APRIL binding affinity, extended non-human primate half-life of approximately 27 days, and sustained IgA suppression In non-human primates, JADE101 showed a differentiated pharmacokinetic and …
Keros Announces Return of $375 Million in Excess Capital to Stockholders
GlobeNewswire
·
June 9, 2025
LEXINGTON, Mass., June 09, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of …
Virtune AB (Publ) ("Virtune") has completed the monthly rebalancing for May 2025 of its Virtune Crypto Altcoin Index ETP
GlobeNewswire
·
June 9, 2025
Stockholm, 9th of June 2025 – Virtune AB (Publ) ("Virtune") today announces that it has completed the monthly rebalancing of the Virtune Crypto Altcoin Index ETP, listed on Nasdaq Stockholm and Nasdaq Helsinki (ISIN code SE0023260716). In addition to the …
Virtune AB (Publ) ("Virtune") har genomfört den månatliga rebalanseringen för maj 2025 av Virtune Crypto Altcoin Index ETP
GlobeNewswire
·
June 9, 2025
Stockholm, 9 juni 2025 – Virtune meddelar idag att man har slutfört den månatliga rebalanseringen av Virtune Crypto Altcoin Index ETP, noterad på Nasdaq Stockholm och Nasdaq Helsinki (ISIN-kod SE0023260716). Utöver Virtune Crypto Altcoin Index ETP omfattar …
Quid Miner's new application dominated the hot search list as soon as it was launched
GlobeNewswire
·
June 9, 2025
Houston, TX, June 09, 2025 (GLOBE NEWSWIRE) -- Quid Miner recently launched a new mobile app: allowing users to mine easily anytime and anywhere. As a green cloud mining platform established legally and compliantly in the UK. It provides mining services …
$ZEUS Announces the Next Era: Trademark Secured, Artist Doxxed, Legacy Unleashed
GlobeNewswire
·
June 9, 2025
Panama City, Panama, June 09, 2025 (GLOBE NEWSWIRE) -- In a sea of derivatives and half-baked memes, $ZEUS is setting a new standard, not just for meme coins, but for storytelling, ownership, and community-driven culture on-chain. Over the past 48 hours, $ …
Red Cat Supports Executive Orders to Strengthen U.S. Drone Manufacturing and National Security
GlobeNewswire
·
June 9, 2025
SAN JUAN, Puerto Rico, June 09, 2025 (GLOBE NEWSWIRE) -- Red Cat Holdings, Inc. (Nasdaq: RCAT), a drone technology company integrating robotic hardware and software for military, government, and commercial operations, today issued a statement of support …
Portage Biotech and Compedica Stock-for-Stock Exchange
GlobeNewswire
·
June 9, 2025
DOVER, Del., June 09, 2025 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage immuno-oncology company formed under the laws of the British Virgin Islands (“Portage”) announce that on June 5, 2025 Portage and Compedica Holdings …
YXT.com's AI Learning Platform Deployed by Siemens for Digital Workforce Transformation
GlobeNewswire
·
June 9, 2025
SUZHOU, China, June 09, 2025 (GLOBE NEWSWIRE) -- YXT.com Group Holding Limited (NASDAQ: YXT) (“YXT.com” or the “Company”), a provider of AI-enabled enterprise productivity solutions, today announced that the global industrial technology leader Siemens has …
WAYS.cash Wins Grand Champion Title at Solrift Hackathon for Privacy-Focused Payment Toolkit
GlobeNewswire
·
June 9, 2025
NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- WAYS.cash, the first self-custodial stealth-address payment toolkit on Solana, has been named Grand Champion of the “A Breach in the Norm” hackathon hosted by Solrift. The win earned the New York–based project a …
CancerVax Targets Liver Cancers to Further Showcase Flexibility of Its Universal Platform
GlobeNewswire
·
June 9, 2025
Lehi, Utah, June 09, 2025 (GLOBE NEWSWIRE) -- CancerVax, Inc., the developer of a breakthrough universal cancer treatment platform designed to use the body’s immune system to treat cancer, today announced that it will expand its preclinical program to …
AB Science announces EMA approval of Masivet shelf-life extension to 4 years
GlobeNewswire
·
June 9, 2025
PRESS RELEASE AB SCIENCE ANNOUNCES EMA APPROVAL OF MASIVET® SHELF-LIFE EXTENSION TO 4 YEARS Paris, June 9, 2025, 8am CET AB Science SA (Euronext - FR0010557264 - AB) today announced that the European Medicine Agency (EMA) has approved the extension of the …
AB Science annonce l’approbation par l’EMA de la prolongation de la durée de conservation de Masivet à 4 ans
GlobeNewswire
·
June 9, 2025
COMMUNIQUE DE PRESSE AB SCIENCE ANNONCE L'APPROBATION PAR L'EMA DE LA PROLONGATION DE LA DURÉE DE CONSERVATION DE MASIVET® À 4 ANS Paris, 9 juin 2025, 8h AB Science SA (Euronext - FR0010557264 - AB) annonce aujourd'hui que l'Agence européenne des …
UPDATE ON THE TERMS OF THE SHAREHOLDERS GENERAL MEETING
GlobeNewswire
·
June 9, 2025
UPDATE ON THE TERMS OF THE SHAREHOLDERS GENERAL MEETING Nantes, June 9th, 2025, 8 a.m. - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) informs its shareholders and the market of the update on the terms of the Combined General Meeting scheduled …
MISE À JOUR DES MODALITÉS DE L’ASSEMBLÉE GÉNÉRALE
GlobeNewswire
·
June 9, 2025
MISE À JOUR DES MODALITÉS DE L’ASSEMBLÉE GÉNÉRALE Nantes, France, 9 juin 2025, 8 heures – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), informe ses actionnaires et le marché de la mise à jour des modalités de l’Assemblée Générale Mixte …
Press Release: Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season
GlobeNewswire
·
June 9, 2025
Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season Paris, June 9, 2025. Sanofi is shipping Beyfortus (nirsevimab) starting in early Q3 to ensure broad availability well ahead of the 2025- …